AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Aug 19, 2014

30071_dirs_2014-08-19_0072f799-6e24-4cd0-a3ee-f4b9d4302e19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-08-15

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-15	ResMed Common Stock	A	28610	—	Acquired	86750.44	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	39130.17	Indirect

Footnotes

F1: Represents performance-based restricted stock units initially granted on November 13, 2013. The shares were earned on August 15, 2014, when the compensation committee certified that the performance metrics were met.